Apollomics (APLM) Total Current Liabilities (2021 - 2025)
Apollomics (APLM) posted quarterly Total Current Liabilities of $388000.0 for Q4 2025, down 93.19% year-on-year from $5.7 million in Q4 2024, and down 40.03% on a QoQ basis from $647000.0 in Q2 2025.
Apollomics (APLM) Total Current Liabilities (2021 - 2025) Analysis & Trends
Apollomics (APLM) has reported Total Current Liabilities for 5 consecutive years, with $388000.0 the latest figure, recorded in Q4 2025.
- Quarterly Total Current Liabilities fell 93.19% year-over-year to $388000.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $388000.0 (down 93.19% YoY) and the FY2025 annual result came in at $388000.0, down 93.19% from the prior year.
- Total Current Liabilities slipped to $388000.0 in Q4 2025 per APLM's latest filing, from $647000.0 in the prior quarter.
- Over the last five years, Total Current Liabilities for APLM reached as high as $64.1 million in Q4 2022 and fell as low as $388000.0 in Q4 2025.
- A 5-year average of $25.7 million and a median of $17.7 million in 2021 frame the typical range for Total Current Liabilities.
- Annual changes were most pronounced in 2022 — Total Current Liabilities surged 372.99% — and 2025, when it sank 97.05%.
- Year by year, Total Current Liabilities stood at $13.6 million in 2021, then jumped by 372.99% to $64.1 million in 2022, then slumped by 34.76% to $41.8 million in 2023, then sank by 86.38% to $5.7 million in 2024, then sank by 93.19% to $388000.0 in 2025.
- According to Business Quant data, Total Current Liabilities over the past three periods registered $388000.0, $647000.0, and $5.7 million for Q4 2025, Q2 2025, and Q4 2024 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 56.01 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | 66.94 Mn |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 1.81 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 6.38 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 3.88 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 5.11 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 1.58 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 289.60 Mn |
| 10 | Apollomics | 2.66 Bn | 2.66 Bn | - | 388,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 388,000.00 |
| Jun 30, 2025 | 647,000.00 |
| Dec 31, 2024 | 5.70 Mn |
| Jun 30, 2024 | 21.92 Mn |
| Dec 31, 2023 | 41.83 Mn |
| Jun 30, 2023 | 57.24 Mn |
| Dec 31, 2022 | 64.12 Mn |
| Dec 31, 2021 | 13.56 Mn |